Cope, Andrew P.

Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling

Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine

T-cell and B-cell ImmunologyRheumatoid Arthritis Research and Therapies

Cited by 287

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · Journal of Clinical Investigation

Rheumatoid Arthritis Research and TherapiesT-cell and B-cell Immunology

Cited by 243

Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study

Wells, P. M., Adebayo, A. S., Bowyer, R. C. E., Freidin, M. B., Finckh, A., Strowig, T., Lesker, T. R., Alpizar-Rodriguez, D., Gilbert, B., Kirkham, B., et al. (2020) · The Lancet Rheumatology

Gut microbiota and healthRheumatoid Arthritis Research and Therapies

Cited by 192

Expression Profiling of Lymphocyte Plasma Membrane Proteins

Peirce, M. J., Wait, R., Begum, S., Saklatvala, J., & Cope, A. P. (2004) · Molecular & Cellular Proteomics

Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and Applications

Cited by 92

Derek Hubert Patrick Cope

Cope, A. P. (2015) · BMJ

Medical History and InnovationsHistory of Medical Practice

Cited by 0